Glenmede Trust’s Synopsys SNPS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.79M Sell
14,609
-3,173
-18% -$1.43M 0.03% 426
2025
Q4
$8.35M Buy
+17,782
New +$7.9M 0.04% 372
2025
Q1
$1M Sell
2,341
-255
-10% -$124K 0.01% 697
2024
Q4
$1.26M Sell
2,596
-37,726
-94% -$19.7M 0.01% 645
2024
Q3
$20.4M Sell
40,322
-5,994
-13% -$3.22M 0.1% 202
2024
Q2
$27.6M Sell
46,316
-23,319
-33% -$13.2M 0.14% 145
2024
Q1
$39.8M Buy
69,635
+9,598
+16% +$5.28M 0.2% 107
2023
Q4
$30.9M Sell
60,037
-30,591
-34% -$15.6M 0.16% 131
2023
Q3
$41.6M Sell
90,628
-161,254
-64% -$72.2M 0.24% 103
2023
Q2
$97.3M Sell
251,882
-244
-0.1% -$98.3K 0.55% 39
2023
Q1
$97.4M Sell
252,126
-20,550
-8% -$7.34M 0.55% 39
2022
Q4
$87.1M Sell
272,676
-15,143
-5% -$4.74M 0.51% 44
2022
Q3
$87.9M Sell
287,819
-6,320
-2% -$2.14M 0.55% 38
2022
Q2
$89.3M Sell
294,139
-27,885
-9% -$8.41M 0.52% 40
2022
Q1
$107M Buy
322,024
+2,468
+0.8% +$770K 0.53% 38
2021
Q4
$118M Sell
319,556
-50,233
-14% -$16.9M 0.56% 37
2021
Q3
$111M Sell
369,789
-21,787
-6% -$6.61M 0.57% 34
2021
Q2
$108M Buy
391,576
+2,953
+0.8% +$749K 0.56% 35
2021
Q1
$96.3M Sell
388,623
-10,900
-3% -$2.77M 0.52% 43
2020
Q4
$104M Buy
399,523
+12,324
+3% +$2.84M 0.57% 35
2020
Q3
$82.9M Buy
387,199
+229,744
+146% +$46.8M 0.5% 47
2020
Q2
$30.7M Sell
157,455
-29,154
-16% -$4.81M 0.19% 128
2020
Q1
$26M Hold
186,609
0.12% 240
2019
Q4
$26M Buy
186,609
+2,534
+1% +$348K 0.12% 240
2019
Q3
$25.3K Buy
184,075
+20,431
+12% +$2.76M 0.12% 239
2019
Q2
$21.1K Buy
163,644
+163,490
+106,162% +$19.7M 0.09% 289
2019
Q1
$17 Sell
154
-657
-81% -$65.1K ﹤0.01% 2148
2018
Q4
$67 Sell
811
-25,291
-97% -$2.25M ﹤0.01% 1478
2018
Q3
$2.57M Sell
26,102
-190,455
-88% -$18.2M 0.01% 603
2018
Q2
$18.5M Sell
216,557
-234,854
-52% -$20.5M 0.08% 311
2018
Q1
$38.5M Hold
451,411
0.16% 196
2017
Q4
$38.5M Sell
451,411
-54,140
-11% -$4.68M 0.16% 196
2017
Q3
$40.7M Buy
505,551
+208,774
+70% +$16.2M 0.18% 174
2017
Q2
$21.4M Hold
296,777
0.1% 280
2017
Q1
$21.4M Buy
296,777
+19,122
+7% +$1.28M 0.1% 280
2016
Q4
$16.3M Sell
277,655
-12,618
-4% -$751K 0.09% 314
2016
Q3
$17.2M Buy
290,273
+240,081
+478% +$13.6M 0.1% 303
2016
Q2
$2.71M Buy
50,192
+132
+0.3% +$6.62K 0.02% 561
2016
Q1
$2.42M Sell
50,060
-402,658
-89% -$17.8M 0.02% 568
2015
Q4
$20.6M Buy
452,718
+45,662
+11% +$2.21M 0.14% 241
2015
Q3
$18.8M Buy
407,056
+25,894
+7% +$1.27M 0.14% 248
2015
Q2
$19.3M Buy
381,162
+340,687
+842% +$16.6M 0.14% 244
2015
Q1
$1.87M Buy
40,475
+40,275
+20,138% +$1.8M 0.01% 612
2014
Q4
$8K Hold
200
﹤0.01% 2245
2014
Q3
$7K Buy
+200
New +$7.93K ﹤0.01% 2185
2014
Q2
Sell
-77,900
Closed -$2.99M 2382
2014
Q1
$2.99M Sell
77,900
-5,045
-6% -$202K 0.03% 483
2013
Q4
$3.36M Sell
82,945
-7,225
-8% -$270K 0.03% 446
2013
Q3
$3.4M Sell
90,170
-5,259
-6% -$195K 0.04% 429
2013
Q2
$3.41M Buy
+95,429
New +$3.39M 0.04% 416

Other funds holding SNPS

Glenmede Trust's SNPS Position: Q1 2026 in Review

Glenmede Trust reduced its Synopsys (SNPS) stake by 18% in Q1 2026, selling an estimated $1.43M and leaving 14,609 shares worth $5.79M. The position accounts for 0.03% of the portfolio, ranked #426.

Glenmede Trust first reported a position in SNPS in Q2 2013 and has held it in 49 quarters since. The position peaked at $118M in Q4 2021. 1,390 funds tracked by Wall St. Rank hold SNPS as of Q1 2026.

  • Glenmede Trust held 14,609 shares of Synopsys worth $5.79M as of Q1 2026.
  • Glenmede Trust sold 3,173 Synopsys shares in Q1 2026, an estimated $1.43M.
  • Synopsys made up 0.03% of Glenmede Trust's portfolio in Q1 2026, its #426 holding.
  • Glenmede Trust first reported a position in Synopsys in Q2 2013 and has held it in 49 quarters since.
  • Glenmede Trust's Synopsys position peaked at $118M in Q4 2021.
  • 1,390 funds tracked by Wall St. Rank held Synopsys as of Q1 2026.

Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.